Form D · Biotechnology
ISI Life Sciences, Inc.
Newport Beach, CA · CIK 0001567736
Offering snapshot reported Apr 23, 2013 · SEC filing
- Reported sold
- $354K Offering amount: $2.5M
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 17, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 23, 2013 | Initial | $354,125 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-195418
Source: Form D, filed Apr 23, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sayed Badrawi | Director |
| David Black | Director |
| Craig Keshishian | Director, Executive |
| Edwin Laird | Director |
| Maurice Mc Sweeney | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
610 Newport Center Drive Suite 500
Newport Beach, CA, 92660
Newport Beach, CA, 92660